Home > Boards > US Listed > Biotechs > WuXi PharmaTech Inc. (WX)

2:04AM WuXi PharmaTech enters into collaboration with Johnson

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 437
Posts 25,896
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
surf1944   Tuesday, 03/02/10 08:49:43 AM
Re: None
Post # of 21 
2:04AM WuXi PharmaTech enters into collaboration with Johnson & Johnson Pharmaceutical R&D, a division of Janssen Pharmaceutica for preclinical services and training (WX) 16.14 : Co announces it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., to collaborate in the area of preclinical services. Under the agreement, WuXi PharmaTech will become a provider of toxicology and other non-clinical services to JANSSEN. In addition, JANSSEN will provide training and other services, reimbursed by WuXi, to establish the GLP quality system and technical capabilities to meet the international standards at WuXi's toxicology facility in Suzhou, China


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences